0      0

AONN+ Annual 2021 Virtual Conference

SAT04 - Industry Sponsored Session | Cosela™: A Novel Myeloprotection Therapy Presented by G1 Therapeutics

Nov 20, 2021 10:30am ‐ Nov 20, 2021 11:30am


Join G1 Therapeutics, Inc., a company focused on next-generation cancer therapies, as they review the current management of chemotherapy-induced myelosuppression (CIM). This presentation will highlight a new therapeutic approach to proactively help protect hematopoietic stem and progenitor cells in the bone marrow from chemotherapy-induced damage. Led by Tajuana Bradley, the session will outline the burden and current treatment landscape of CIM and present important information about a novel treatment. Mechanism of action, safety and efficacy data, and dosing and administration information will be discussed.


You must be logged in and own this session in order to post comments.